Vnitr Lek 2010, 56(6):488-493

Is there circadian variation of big endothelin and NT-proBNP in patients with severe congestive heart failure?

O. Ludka1,*, J. ©pinar1, Z. Pozdíąek1, V. Musil1, L. ©pinarová2, J. Vítovec2, J. Tomandl3
1 Interní kardiologická klinika Lékařské fakulty MU a FN Brno, pracoviątě Bohunice, přednosta prof. MUDr. Jindřich ©pinar, CSc., FESC
2 I. interní kardio-angiologická klinika Lékařské fakulty MU a FN u sv. Anny Brno, přednosta prof. MUDr. Jiří Vítovec, CSc., FESC
3 Biochemický ústav Lékařské fakulty MU Brno, přednostka prof. RNDr. Eva Táborská, CSc.

Introduction:
Circadian rhytmus have long been recognized to occur in many biologic phenomena, including secretion of hormones as well as autonomic nervous system. There is increasing evidence that circadian rhythms have been also found in cardiovascular events, for example, myocardial infarction, sudden cardiac death as well as stroke have shown a circadian pattern of the distribution. The pathophysiology and the mechanism underlying these variations are the focus of much investigation, while i tis not full understood up to date. Heart rate, blood pressure, neurohumoral vasoactive factors, such as plasma norepinephrine levels and renin activity, and probably also contractility are increased in the morning hours.

Aim:
The aim of our study was to evaluate the circadian variability of plasma big endothelin and NT-proBNP level in patients with severe heart failure.


Patients:
13 patients with severe heart failure, stable for at least one month, male/female - 8/5, NYHA III/IV - 11/2, mean left ventricle ejection fraction 23 ± 5 %, mean cardiothoracic ratio 59 ± 7 %, all treated with RAAS blocade (11× ACE-I, 2× ARB), all treated with diuretics, 12 patients treated with beta-blockers, 7 with digoxin. The cause of heart failure was ischemic heart disease (9) or dilated cardiomyopathy (4).

Methods:
Blood samples for big endothelin and NT-proBNP were taken every two hours during a standartised daily regime.

Results:
Mean plasma level of big endothelin (ranging from 1.25 to 1.71 pmol/l) had significant diurnal variability (upper limit of normal values 0.7 pmol/l). Mean plasma level of NT-proBNP (ranging from 782 to 934 pmol/l) had no diurnal variability (upper limit of normal values of 350 pmo/l).


Summary:
Plasma level of NT-proBNP is stable during 24 hours and shows no circadian variability. Plasma big endothelin showed a morning peak after a systematic increase during bed rest. NT-proBNP could be evaluated any time during the day, big endothelin sample should be taken during standartised condition.

Keywords: NT-proBNP; big endothelin; circadian variation; heart failure

Received: December 7, 2009; Accepted: February 17, 2010; Published: June 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ludka O, ©pinar J, Pozdíąek Z, Musil V, ©pinarová L, Vítovec J, Tomandl J. Is there circadian variation of big endothelin and NT-proBNP in patients with severe congestive heart failure? Vnitr Lek. 2010;56(6):488-493.
Download citation

References

  1. Bartůněk L. Endoteliny a chronická srdeční insuficience. Vnitř Lék 2000; 46: 54-57. Go to PubMed...
  2. Frelin C, Guedin H. Why are circulating concentrations of endothelin-1 so low? Cardiovasc Res 1994; 28: 1613-1622. Go to original source... Go to PubMed...
  3. Pacher R, Stanek B, Hüelsmann M et al. Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure. J Am Coll Cardiol 1996; 27: 633-641. Go to original source... Go to PubMed...
  4. Sharma RB, Coats AJ, Anker SD. The role of inflammatory mediators in chronic heart failure: cytokines, nitric oxide, and endothelin-1. Int J Cardiol 2000; 72: 175-186. Go to original source... Go to PubMed...
  5. ©pinar J, ©pinarová L, Vítovec J et al. Big endothelin and chronic heart failure. Vnitř Lék 2002; 48: 3-7.
  6. Gardner RS, Ozalp F, Murday AJ et al. N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure. Eur Heart J 2003; 24: 1735-1743. Go to original source... Go to PubMed...
  7. ©pinarová L, Toman J. Humorální změny u chronického srdečního selhání. Cor Vasa 2001; 43: 513-519.
  8. Eguchi K, Kario K, Shimada K et al. Circadian variation of blood pressure and neurohumoral factors during the acute phase of stroke. Clin Exp Hypertens 2002; 24: 109-114. Go to original source... Go to PubMed...
  9. Bruins S, Fokkema MR, Römer JW et al. High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure. Clin Chem 2004; 50: 2052-2058. Go to original source... Go to PubMed...
  10. Elherik K, Khan F, McLaren M et al. Circadian variation in vascular tone and endothelial cell function in normal males. Clin Sci (Lond.) 2002; 102: 547-552. Go to original source... Go to PubMed...
  11. Herold M, Cornélissen G, Loeckinger A et al. About 8-hour variation of circulating human endothelin-1. Peptides 1998; 19: 821-825. Go to original source... Go to PubMed...
  12. Maeda M, Kachi H, Takagi H et al. Is there circadian variation of plasma endothelin (ET-1) in patients with systemic scleroderma (SSc)? J Dermatol Sci 1997; 16: 38-44. Go to original source... Go to PubMed...
  13. Li JJ, Huang CX, Fang CH et al. Circadian variation in ischemic threshold in patients with stable angina: relation to plasma endothelin-1. Angiology 2002; 53: 409-413. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.